Detect Kidney Damage
Whatever the reason is.
Revolutionizing Kidney Health Diagnostics
At PRELIQX, we are dedicated to advancing kidney health through innovation. Nephronin®, our innovative sensitive and specific test, is designed to address a critical gap in the early and accurate detection of kidney damage.
Understanding Kidney Damage
Kidney damage can result from various risk factors, including diabetes, high blood pressure, heart disease, chronic infections, and prolonged exposure to toxins or certain medications. Lifestyle, genetic conditions, and aging further increase the risk.
Approximately 850 million individuals across the globe are living with various forms of kidney disease. Among these, Chronic Kidney Disease (CKD) impacts ~10% of the world's population, highlighting its widespread prevalence. Additionally, Acute Kidney Injury (AKI) is seen in up to 22% of patients who are hospitalized, underscoring the severity and urgency of addressing kidney health in medical settings.
Enhancing Kidney Damage Detection with an Expanded Diagnosis Window
Kidney disease is called a “silent killer” because it often shows no symptoms. This makes it hard for patients, as early detection is crucial to prevent kidney failure. Conventional markers often miss early kidney damage, leading to delayed diagnosis after significant function loss. There is a need for non-invasive, sensitive biomarkers to expand the diagnosis window. Nephronin® seeks to complement the traditional markers for earlier detection and improved patient outcomes.
Why to Use Nephronin®?
Our non-invasive test uses a simple urine sample to identify specific biomarkers associated with kidney injury. Traditional biomarkers, like serum creatinine, typically only reflect kidney function after significant damage has already occurred to nephrons. However, Nephronin® detects kidney damage biomarkers at the molecular level, allowing it to identify kidney damage at its earliest stages.
Comprehensive Kidney Health Monitoring Across Multiple Indications
Nephronin® has broad potential applications, including early detection and monitoring of acute and chronic kidney diseases, renal function assessment during nephrotoxic treatments, post-surgery, and after kidney transplantation. It aids critical care by identifying early kidney injury in hospitalized patients and supports drug development by evaluating renal safety. Additionally, it is valuable for routine kidney health screening, especially in at-risk populations and older adults.
Collaborate
Join us in advancing kidney health diagnostics for better, more personalized healthcare. Whether you're a clinician, researcher, investor, patient, insurance company, or part of the industry, we'd love to connect and collaborate with you.
